Billions of Dollars on the Line for Celgene With These 3 Small Biotechs – Madison.com
Madison.com |
Billions of Dollars on the Line for Celgene With These 3 Small Biotechs
Madison.com In 2015, Celgene forged another relationship with a small biotech specializing in treating cancer via chimeric antigen receptor T–cell (CAR-T) therapies — Juno Therapeutics. The deal involved collaboration on several of Juno’s immunotherapy candidates. |
Monroe Evening News |
Immunotherapy drug targets tumor’s genetics instead of body part
Monroe Evening News Whatever the tumor, the more gene mutations lurking inside, the better chance your immune system has to fight back. That’s the premise behind the recent approval of a landmark drug, the first cancer therapy ever cleared based on a tumor’s genetics … Landmark Cancer Drug Spurs Immune SystemSci-Tech Today Tumor gene testing urged to tell if drug targets your cancerKRQE News 13 |
|
Global Specific Cancer Immunotherapy Drugs Market 2021: Industrial Forecast and Analysis
Medgadget (blog) “Global Specific Cancer Immunotherapy Drugs Market Research Report Forecast 2017 To 2021” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. This market research report gives an in-depth idea about the global Specific … |
Business Insider |
Private clinics are peddling untested, dangerous stem cell …
Business Insider Stem cells have saved thousands of lives. But some uses peddled by private clinics are without evidence. Researcher warns of risks associated with unregulated stem cell …Globalnews.ca Private clinics are peddling untested stem cell treatments — it’s …Yahoo News UK |
Wall Street Journal (subscription) |
Crispr Patent-Holders Move Toward Easing Access to Gene-Editing Technology
Wall Street Journal (subscription) A holder of key patents to the Crispr gene-editing technology is willing to join a world-wide joint patent pool—a development that medical and legal experts think could hasten the development of new human therapies. The Broad Institute of MIT and … |
Washington Post |
‘Stem–cell tourism’ needs tighter controls, say medical experts
Washington Post Stem cell tourism — in which patients travel to developing countries for unproven and potentially risky therapies — should be more tightly regulated, according to a group of international health experts. With hundreds of medical centers around the … Stem Cell Therapy: You can be sexually active againVanguard Stem Cell Educator therapy found to be safe and effective for treating diabetesNews-Medical.net |